Beata Rutz
Munich, BY 81377, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Pine-Extracted Phytosterol β-Sitosterol (APOPROSTAT® Forte) Inhibits Both Human Prostate Smooth Muscle Contraction and Prostate Stromal Cell Growth, Without Cytotoxic Effects: A Mechanistic Link to Clinical Efficacy in LUTS/BPH.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 19, 2025
Dynamic phenotypic shifts and M2 receptor downregulation in bladder smooth muscle cells induced by mirabegron.
Journal: Frontiers in pharmacology
Published: June 10, 2024
Immunomodulatory imide drugs inhibit human detrusor smooth muscle contraction and growth of human detrusor smooth muscle cells, and exhibit vaso-regulatory functions.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 17, 2024
Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003.
Journal: Frontiers in pharmacology
Published: November 23, 2022
Permixon®, hexane-extracted Serenoa repens, inhibits human prostate and bladder smooth muscle contraction and exerts growth-related functions in human prostate stromal cells.
Journal: Life sciences
Published: July 22, 2022
Inhibition of Human Prostate and Bladder Smooth Muscle Contraction, Vasoconstriction of Porcine Renal and Coronary Arteries, and Growth-Related Functions of Prostate Stromal Cells by Presumed Small Molecule Gαq/11 Inhibitor, YM-254890.
Journal: Frontiers in physiology
Published: February 25, 2022
ADP Ribosylation Factor 6 Promotes Contraction and Proliferation, Suppresses Apoptosis and Is Specifically Inhibited by NAV2729 in Prostate Stromal Cells.
Journal: Molecular pharmacology
Published: April 04, 2021
Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: September 30, 2020
Inhibition of neurogenic and thromboxane A2 -induced human prostate smooth muscle contraction by the integrin α2β1 inhibitor BTT-3033 and the integrin-linked kinase inhibitor Cpd22.
Journal: The Prostate
Published: January 14, 2020
Last Updated: 09/26/2026